Related Experiment Video
Updated: Aug 15, 2026

09:08
Multiple-mouse Neuroanatomical Magnetic Resonance Imaging
Published on: February 27, 2011
Gimatecan (sigma-tau industrie farmaceutiche riunite/novartis)
John L Nitiss1, Karin C Nitiss
1St Jude Children's Research Hospital, Molecular Pharmacology Department, 332 N Lauderdale Street, Memphis, TN 38105, USA. john.nitiss@stjude.org
Abstract:
Sigma-Tau Industrie Farmaceutiche Riunite SpA and Novartis AG are developing oral gimatecan, a camptothecin derivative, for the potential treatment of tumors, including glioblastoma.

